Progress in the treatment of Osteoarthritis with avocado-soybean unsaponifiable
- PMID: 38814416
- DOI: 10.1007/s10787-024-01496-x
Progress in the treatment of Osteoarthritis with avocado-soybean unsaponifiable
Abstract
Osteoarthritis (OA) is one of the leading causes of joint dysfunction and disability in the elderly, posing serious social problems and a huge socio-economic burden. Existing pharmacological treatments have significant drawbacks, and searching for an effective pharmacological intervention is an urgent priority. Recent studies have demonstrated the chondroprotective, anabolic, and anti-catabolic properties of avocado-soybean unsaponifiable (ASU), a natural plant extract made from avocado and soybean oils, consisting of the remainder of the saponified portion of the product that cannot be made into soap. The main components of ASU are phytosterols, beta-sitosterol, canola stanols, and soya stanols, which are rapidly incorporated into cells. Studies have confirmed the anti-inflammatory, antioxidant, and analgesic properties of phytosterols. ASU slows down the progression of OA primarily by inhibiting pathways involved in the development of OA disease. ASU prevents cartilage degradation by inhibiting the release and activity of matrix metalloproteinases and by increasing the tissue inhibition of these catabolic enzymes; ASU is also involved in the inhibition of the activation of nuclear factor κB (NF-κB) which is a transcriptional inhibitor that regulates the inflammatory response of chondrocytes. NF-κB is a transcription factor that regulates the inflammatory response of chondrocytes, and inhibition of the transfer of the transcription factor NF-κB from the cytoplasm to the nucleus regulates the transcription of many pro-inflammatory factors. By appealing to the mechanism of action and thus achieving anti-inflammatory, anti-catabolic, and pro-synthetic effects on cartilage tissues, AUS is clinically responsive to the reduction of acute pain and OA symptom progression. This paper aims to summarize the studies on the use of avocado-soybean unsaponifiable in the pharmacological treatment of osteoarticular.
Keywords: Anti-catabolism; Anti-inflammatory effects; Avocado–soybean unsaponifiable; Inflammatory mediators; Osteoarthritis.
© 2024. The Author(s), under exclusive licence to Springer Nature Switzerland AG.
Similar articles
-
α-Lipoic Acid Potentiates the Anti-Inflammatory Activity of Avocado/Soybean Unsaponifiables in Chondrocyte Cultures.Cartilage. 2018 Jul;9(3):304-312. doi: 10.1177/1947603516686146. Epub 2017 Jan 10. Cartilage. 2018. PMID: 29156944 Free PMC article.
-
Stress-induced signaling pathways in hyalin chondrocytes: inhibition by Avocado-Soybean Unsaponifiables (ASU).Osteoarthritis Cartilage. 2008 Mar;16(3):373-84. doi: 10.1016/j.joca.2007.06.016. Epub 2007 Aug 17. Osteoarthritis Cartilage. 2008. PMID: 17707661
-
Avocado-Soybean Unsaponifiables: A Panoply of Potentialities to Be Exploited.Biomolecules. 2020 Jan 13;10(1):130. doi: 10.3390/biom10010130. Biomolecules. 2020. PMID: 31940989 Free PMC article. Review.
-
Protective effects of total fraction of avocado/soybean unsaponifiables on the structural changes in experimental dog osteoarthritis: inhibition of nitric oxide synthase and matrix metalloproteinase-13.Arthritis Res Ther. 2009;11(2):R41. doi: 10.1186/ar2649. Epub 2009 Mar 16. Arthritis Res Ther. 2009. PMID: 19291317 Free PMC article.
-
Efficacy and safety of avocado-soybean unsaponifiables for the treatment of hip and knee osteoarthritis: A systematic review and meta-analysis of randomized placebo-controlled trials.Int J Rheum Dis. 2019 Sep;22(9):1607-1615. doi: 10.1111/1756-185X.13658. Epub 2019 Jul 22. Int J Rheum Dis. 2019. PMID: 31328413
Cited by
-
Diet in Knee Osteoarthritis-Myths and Facts.Nutrients. 2025 May 30;17(11):1872. doi: 10.3390/nu17111872. Nutrients. 2025. PMID: 40507141 Free PMC article. Review.
-
Suppressive effect of curcumin on apoptosis of articular chondrocytes via regulation on NF-κB pathway and NLRP3 inflammasome.Cytotechnology. 2025 Apr;77(2):52. doi: 10.1007/s10616-024-00695-2. Epub 2025 Jan 31. Cytotechnology. 2025. PMID: 39897107
References
-
- Akdis M, Burgler S, Crameri R, Eiwegger T, Fujita H, Gomez E, Klunker S, Meyer N, O’Mahony L, Palomares O, Rhyner C, Ouaked N, Schaffartzik A, Van De Veen W, Zeller S, Zimmermann M, Akdis CA (2011) Interleukins from 1 to 37 and interferon γ receptors functions and roles in diseases. J Allergy Clin Immunol 127(3):701-721.e70. https://doi.org/10.1016/j.jaci.2010.11.050 - DOI - PubMed
-
- Appelboom T, Schuermans J, Verbruggen G, Henrotin Y, Reginster JY (2001) Symptoms modifying effect of avocado/soybean unsaponifiables (Asu) in knee osteoarthritis. a double-blind, prospective, placebo-controlled study. Scand J Rheumatol 30(4):242–247. https://doi.org/10.1080/030097401316909602 - DOI - PubMed
-
- Au RY, Al-Talib TK, Au AY, Phan PV, Frondoza CG (2007) Avocado soybean unsaponifiables (Asu) suppress tnf-alpha, Il-1beta, cox-2, Inos gene expression, and prostaglandin e2 and nitric oxide production in articular chondrocytes and monocyte/macrophages. Osteoarthritis Cartilage 15(11):1249–1255. https://doi.org/10.1016/j.joca.2007.07.009 - DOI - PubMed
-
- Bischoff SC, Krieger M, Brunner T, Rot A, von Tscharner V, Baggiolini M, Dahinden CA (1993) Rantes and related chemokines activate human basophil granulocytes through different G protein-coupled receptors. Eur J Immunol 23(3):761–767. https://doi.org/10.1002/eji.1830230329 - DOI - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Medical